Acrux Ltd (ASX:ACR) a specialty pharma company that develops and commercialises drugs.
Presenting Thu, 5:00 PM · John Warmbrunn, CEO
Presenting companies
Meet 56 Biotechs
Browse the full slate, save companies to your list, and request a 1:1 meeting at the conference or virtually after.
Presenting Thu, 12:20 PM · Steven Gourlay, CEO
"East to West" cellular immunotherapies and protein therapeutics for fatal diseases.
Not presenting
Not presenting
Amplia (ASX:ATX) has a highly promising drug in Phase 2 studies for solid tumours.
Presenting Thu, 12:35 PM · Chris Burns, CEO
Clinical-stage gene therapy medicines for neuromuscular diseases.
Not presenting
High-growth, profitable soft tissue regeneration company with US commercial operations.
Presenting Thu, 9:00 AM · Brian Ward, CEO · also Thu, 11:50 AM (James Agnew, CFO)
Clinical-stage CAR-iNKT company developing off-the-shelf cell therapies.
Not presenting
AI-powered coronary artery disease detection from a single CT scan.
Presenting Thu, 5:30 PM
Transforming the treatment of bipolar mania.
Not presenting
A blood test for earlier, more accurate breast cancer detection.
Presenting Thu, 3:00 PM
Presenting Thu, 2:30 PM · Henk-Jan Boele, CEO
CDH17 CAR-T for GI and neuroendocrine cancers. Reaching the unreachable.
Presenting Fri, 4:20 PM · Rebecca McQualter, CEO
Clarity is a clinical-stage radiopharmaceutical company developing cancer theranostics.
Presenting Thu, 10:10 AM · Alan Taylor, CEO
Cleo is developing a simple blood test for the early and accurate detection of ovarian cancer.
Presenting Thu, 3:10 PM · Dayna Louca, Head of Corp. Dev.
Commercial-stage AI-powered microbiology automation for pharma manufacturing.
Presenting Fri, 2:30 PM · Brent Barnes, CEO
Profitable global CNS tech leader enabling faster, higher-quality clinical trials.
Presenting Thu, 4:40 PM · Brad O'Connor, CEO
Late-stage therapies for kidney and inflammatory disease. DMX-200 in Phase 3.
Presenting Thu, 11:30 AM
Presenting Fri, 4:40 PM · Mary-Ann Rennie, CEO
Presenting Fri, 4:30 PM
Clinical stage, next generation cancer therapeutics for adult and paediatric patients.
Presenting Fri, 12:35 PM · Christian Toouli, CEO
HGX is a clinical-stage biotech developing precision therapies for multiple myeloma.
Presenting Fri, 11:00 AM · Chris Baldwin, CEO
Not presenting
Immuron is an enteric diseases platform company with commercial revenue and clinical-stage assets.
Not presenting
Developing next-generation multispecific biologic medicines for serious diseases.
Presenting Fri, 10:45 AM · Philippa Lewis, CEO
INOVIQ is pioneering exosome-based diagnostics and therapeutics that transform cancer care.
Presenting Thu, 2:40 PM · Leearne Hinch, CEO
Clinical-stage antivirals with expedited paths for Marburg, Ebola & dengue.
Presenting Fri, 3:35 PM · David Foster, CEO
Lateral Pharma is developing new drugs to treat and increase healthy longevity.
Presenting Thu, 5:15 PM · David Kenley, CEO
Clinical-stage biotech developing pathogen-agnostic AMR breakers.
Presenting Fri, 2:45 PM · Maud Eijkenboom, MD
Specialising in rapid, cost-effective and complete point-of-care diagnostic test solutions.
Presenting Fri, 3:05 PM
Specialty pharma advancing women's health and dermatology.
Presenting Thu, 9:50 AM · Aaron Gray, CEO
The Type 2 diabetes therapeutic market is globally $130 billion. Despite this, current therapies still fail to adequately address the core drivers of disease progression: inflammation, metabolic dysfunction, and loss of beta cell function.
Not presenting
Clinical-stage biotech developing proprietary psychedelic medicines for PTSD and MDD.
Not presenting
Neuren is developing new drug therapies to treat multiple serious neurological disorders.
Presenting Thu, 9:30 AM · Jon Pilcher, CEO
Not presenting
Not presenting
Maker of iTrack™ Advance, an implant-free minimally invasive glaucoma surgery device.
Not presenting
The global diagnostics company behind Cxbladder urine biomarker cancer tests.
Presenting Thu, 3:30 PM · Peter Meintjes, CEO
A clinical-stage therapeutic developer focused on a solution for attenuating delirium.
Presenting Fri, 11:40 AM · Samantha South, CEO
An immuno-oncology company with positive Phase I data from the US, about to start Phase II.
Not presenting
PLL Tx Australia is driving a new approach to MND diagnosis and therapy, targeting ALS.
Not presenting
ASX:PTX – clinical-stage oncology company developing PTX-100, a GGT-1ase inhibitor.
Not presenting
Earlier prediction. Informed decisions. Better outcomes.
Presenting Thu, 3:20 PM · David Morris, CEO
Clinical-stage biotech developing natural-source therapies for oncology and wound healing.
Not presenting
Racura Oncology is a Phase 3 stage clinical biopharmaceutical company on a mission to silence cancer.
Presenting Fri, 12:15 PM · Peter Smith, CEO
Presenting Fri, 3:20 PM · James Graham, CEO
Not presenting
Not presenting
An Australian innovative medical diagnostics company delivering simple, affordable blood tests for accurate, early detection of cancers.
Presenting Thu, 2:50 PM · David Atkins, CEO
Presenting Fri, 11:55 AM · Cheryl Maley, CEO
Presenting Thu, 12:05 PM · Gary Phillips, CEO
SYNthesis med chem, a global provider of integrated drug discovery & development services.
Not presenting
Commercial-stage radiopharmaceutical company advancing targeted cancer diagnostics and therapies.
Presenting Thu, 10:30 AM
First-in-class antifibrotic drug developer targeting pulmonary fibrosis.
Presenting Fri, 4:50 PM · Tara Speranza, CEO
Smart cryopreservation hardware and software preserving biomaterial quality (ASX:VFY).
Presenting Fri, 11:25 AM · Brent Owens, CEO